Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 15, 2022

Immune Response and Safety of the SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis

Neurology(R) Neuroimmunology & Neuroinflammation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Neurology(R) Neuroimmunology & Neuroinflammation
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
Neurol Neuroimmunol Neuroinflamm 2022 Jul 01;[EPub Ahead of Print], D Reyes-Leiva, J López-Contreras, E Moga, F Pla-Juncà, E Lynton-Pons, R Rojas-Garcia, J Turon-Sans, L Querol, M Olive, R Álvarez-Velasco, M Caballero-Ávila, Á Carbayo, A Vesperinas-Castro, P Domingo, I Illa, E Gallardo, E Cortés-Vicente

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading